Načítá se...
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Multiple myeloma (MM) is a plasma cell malignancy that is characterized by immune dysregulation. MM is commonly treated with immunomodulating agents, but still remains incurable. Herein, we proposed and evaluated immunostimulatory Lokon oncolytic adenoviruses (LOAd) for MM treatment. LOAd viruses ar...
Uloženo v:
| Vydáno v: | Cancer Gene Ther |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group US
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7725669/ https://ncbi.nlm.nih.gov/pubmed/32355275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-020-0176-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|